 | • レポートコード：MRC2-11QY13064 • 出版社/出版日：QYResearch / 2020年11月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、111ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はボグリボースのグローバル市場について調査・分析したレポートです。種類別（錠剤、カプセル、その他）市場規模、用途別（病院、診療所、ドラッグストア、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別ボグリボースの競争状況、市場シェア ・世界のボグリボース市場：種類別市場規模 2015年-2020年（錠剤、カプセル、その他） ・世界のボグリボース市場：種類別市場規模予測 2021年-2026年（錠剤、カプセル、その他） ・世界のボグリボース市場：用途別市場規模 2015年-2020年（病院、診療所、ドラッグストア、その他） ・世界のボグリボース市場：用途別市場規模予測 2021年-2026年（病院、診療所、ドラッグストア、その他） ・北米のボグリボース市場分析：米国、カナダ ・ヨーロッパのボグリボース市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのボグリボース市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のボグリボース市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのボグリボース市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Eris、Pfizer Limited、AS Pharma、Sarian、Three Dots Lifesciences、Strides、Blue Cross、Life Care、Nexus Biotech、Neelkanth Healthcare (P)Ltd、Panacea Biotec Ltd、Unichem ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Voglibose Market
The global Voglibose market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Voglibose Scope and Market Size
Voglibose market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Voglibose market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Voglibose market is segmented into
Tabelts
Capsules
Others
Segment by Application, the Voglibose market is segmented into
Hospital
Clinics
Drug Store
Others
Regional and Country-level Analysis
The Voglibose market is analysed and market size information is provided by regions (countries).
The key regions covered in the Voglibose market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Voglibose Market Share Analysis
Voglibose market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Voglibose business, the date to enter into the Voglibose market, Voglibose product introduction, recent developments, etc.
The major vendors covered:
Eris
Pfizer Limited
AS Pharma
Sarian
Three Dots Lifesciences
Strides
Blue Cross
Life Care
Nexus Biotech
Neelkanth Healthcare (P)Ltd
Panacea Biotec Ltd
Unichem
1 Study Coverage
1.1 Voglibose Product Introduction
1.2 Market Segments
1.3 Key Voglibose Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Voglibose Market Size Growth Rate by Type
1.4.2 Tabelts
1.4.3 Capsules
1.4.4 Others
1.5 Market by Application
1.5.1 Global Voglibose Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinics
1.5.4 Drug Store
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Voglibose Market Size, Estimates and Forecasts
2.1.1 Global Voglibose Revenue 2015-2026
2.1.2 Global Voglibose Sales 2015-2026
2.2 Global Voglibose, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Voglibose Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Voglibose Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Voglibose Competitor Landscape by Players
3.1 Voglibose Sales by Manufacturers
3.1.1 Voglibose Sales by Manufacturers (2015-2020)
3.1.2 Voglibose Sales Market Share by Manufacturers (2015-2020)
3.2 Voglibose Revenue by Manufacturers
3.2.1 Voglibose Revenue by Manufacturers (2015-2020)
3.2.2 Voglibose Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Voglibose Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Voglibose Revenue in 2019
3.2.5 Global Voglibose Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Voglibose Price by Manufacturers
3.4 Voglibose Manufacturing Base Distribution, Product Types
3.4.1 Voglibose Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Voglibose Product Type
3.4.3 Date of International Manufacturers Enter into Voglibose Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Voglibose Market Size by Type (2015-2020)
4.1.1 Global Voglibose Sales by Type (2015-2020)
4.1.2 Global Voglibose Revenue by Type (2015-2020)
4.1.3 Voglibose Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Voglibose Market Size Forecast by Type (2021-2026)
4.2.1 Global Voglibose Sales Forecast by Type (2021-2026)
4.2.2 Global Voglibose Revenue Forecast by Type (2021-2026)
4.2.3 Voglibose Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Voglibose Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Voglibose Market Size by Application (2015-2020)
5.1.1 Global Voglibose Sales by Application (2015-2020)
5.1.2 Global Voglibose Revenue by Application (2015-2020)
5.1.3 Voglibose Price by Application (2015-2020)
5.2 Voglibose Market Size Forecast by Application (2021-2026)
5.2.1 Global Voglibose Sales Forecast by Application (2021-2026)
5.2.2 Global Voglibose Revenue Forecast by Application (2021-2026)
5.2.3 Global Voglibose Price Forecast by Application (2021-2026)
6 North America
6.1 North America Voglibose by Country
6.1.1 North America Voglibose Sales by Country
6.1.2 North America Voglibose Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Voglibose Market Facts & Figures by Type
6.3 North America Voglibose Market Facts & Figures by Application
7 Europe
7.1 Europe Voglibose by Country
7.1.1 Europe Voglibose Sales by Country
7.1.2 Europe Voglibose Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Voglibose Market Facts & Figures by Type
7.3 Europe Voglibose Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Voglibose by Region
8.1.1 Asia Pacific Voglibose Sales by Region
8.1.2 Asia Pacific Voglibose Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Voglibose Market Facts & Figures by Type
8.3 Asia Pacific Voglibose Market Facts & Figures by Application
9 Latin America
9.1 Latin America Voglibose by Country
9.1.1 Latin America Voglibose Sales by Country
9.1.2 Latin America Voglibose Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Voglibose Market Facts & Figures by Type
9.3 Central & South America Voglibose Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Voglibose by Country
10.1.1 Middle East and Africa Voglibose Sales by Country
10.1.2 Middle East and Africa Voglibose Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Voglibose Market Facts & Figures by Type
10.3 Middle East and Africa Voglibose Market Facts & Figures by Application
11 Company Profiles
11.1 Eris
11.1.1 Eris Corporation Information
11.1.2 Eris Description and Business Overview
11.1.3 Eris Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eris Voglibose Products Offered
11.1.5 Eris Related Developments
11.2 Pfizer Limited
11.2.1 Pfizer Limited Corporation Information
11.2.2 Pfizer Limited Description and Business Overview
11.2.3 Pfizer Limited Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Limited Voglibose Products Offered
11.2.5 Pfizer Limited Related Developments
11.3 AS Pharma
11.3.1 AS Pharma Corporation Information
11.3.2 AS Pharma Description and Business Overview
11.3.3 AS Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 AS Pharma Voglibose Products Offered
11.3.5 AS Pharma Related Developments
11.4 Sarian
11.4.1 Sarian Corporation Information
11.4.2 Sarian Description and Business Overview
11.4.3 Sarian Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Sarian Voglibose Products Offered
11.4.5 Sarian Related Developments
11.5 Three Dots Lifesciences
11.5.1 Three Dots Lifesciences Corporation Information
11.5.2 Three Dots Lifesciences Description and Business Overview
11.5.3 Three Dots Lifesciences Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Three Dots Lifesciences Voglibose Products Offered
11.5.5 Three Dots Lifesciences Related Developments
11.6 Strides
11.6.1 Strides Corporation Information
11.6.2 Strides Description and Business Overview
11.6.3 Strides Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Strides Voglibose Products Offered
11.6.5 Strides Related Developments
11.7 Blue Cross
11.7.1 Blue Cross Corporation Information
11.7.2 Blue Cross Description and Business Overview
11.7.3 Blue Cross Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Blue Cross Voglibose Products Offered
11.7.5 Blue Cross Related Developments
11.8 Life Care
11.8.1 Life Care Corporation Information
11.8.2 Life Care Description and Business Overview
11.8.3 Life Care Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Life Care Voglibose Products Offered
11.8.5 Life Care Related Developments
11.9 Nexus Biotech
11.9.1 Nexus Biotech Corporation Information
11.9.2 Nexus Biotech Description and Business Overview
11.9.3 Nexus Biotech Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Nexus Biotech Voglibose Products Offered
11.9.5 Nexus Biotech Related Developments
11.10 Neelkanth Healthcare (P)Ltd
11.10.1 Neelkanth Healthcare (P)Ltd Corporation Information
11.10.2 Neelkanth Healthcare (P)Ltd Description and Business Overview
11.10.3 Neelkanth Healthcare (P)Ltd Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Neelkanth Healthcare (P)Ltd Voglibose Products Offered
11.10.5 Neelkanth Healthcare (P)Ltd Related Developments
11.1 Eris
11.1.1 Eris Corporation Information
11.1.2 Eris Description and Business Overview
11.1.3 Eris Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Eris Voglibose Products Offered
11.1.5 Eris Related Developments
11.12 Unichem
11.12.1 Unichem Corporation Information
11.12.2 Unichem Description and Business Overview
11.12.3 Unichem Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Unichem Products Offered
11.12.5 Unichem Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Voglibose Market Estimates and Projections by Region
12.1.1 Global Voglibose Sales Forecast by Regions 2021-2026
12.1.2 Global Voglibose Revenue Forecast by Regions 2021-2026
12.2 North America Voglibose Market Size Forecast (2021-2026)
12.2.1 North America: Voglibose Sales Forecast (2021-2026)
12.2.2 North America: Voglibose Revenue Forecast (2021-2026)
12.2.3 North America: Voglibose Market Size Forecast by Country (2021-2026)
12.3 Europe Voglibose Market Size Forecast (2021-2026)
12.3.1 Europe: Voglibose Sales Forecast (2021-2026)
12.3.2 Europe: Voglibose Revenue Forecast (2021-2026)
12.3.3 Europe: Voglibose Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Voglibose Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Voglibose Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Voglibose Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Voglibose Market Size Forecast by Region (2021-2026)
12.5 Latin America Voglibose Market Size Forecast (2021-2026)
12.5.1 Latin America: Voglibose Sales Forecast (2021-2026)
12.5.2 Latin America: Voglibose Revenue Forecast (2021-2026)
12.5.3 Latin America: Voglibose Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Voglibose Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Voglibose Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Voglibose Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Voglibose Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Voglibose Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Voglibose Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Voglibose Market Segments
Table 2. Ranking of Global Top Voglibose Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Voglibose Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Tabelts
Table 5. Major Manufacturers of Capsules
Table 6. Major Manufacturers of Others
Table 7. Global Voglibose Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Voglibose Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Voglibose Sales by Regions 2015-2020 (K MT)
Table 10. Global Voglibose Sales Market Share by Regions (2015-2020)
Table 11. Global Voglibose Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Voglibose Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Voglibose Sales Share by Manufacturers (2015-2020)
Table 14. Global Voglibose Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Voglibose by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Voglibose as of 2019)
Table 16. Voglibose Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Voglibose Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Voglibose Price (2015-2020) (USD/MT)
Table 19. Voglibose Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Voglibose Product Type
Table 21. Date of International Manufacturers Enter into Voglibose Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Voglibose Sales by Type (2015-2020) (K MT)
Table 24. Global Voglibose Sales Share by Type (2015-2020)
Table 25. Global Voglibose Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Voglibose Revenue Share by Type (2015-2020)
Table 27. Voglibose Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Voglibose Sales by Application (2015-2020) (K MT)
Table 29. Global Voglibose Sales Share by Application (2015-2020)
Table 30. North America Voglibose Sales by Country (2015-2020) (K MT)
Table 31. North America Voglibose Sales Market Share by Country (2015-2020)
Table 32. North America Voglibose Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Voglibose Revenue Market Share by Country (2015-2020)
Table 34. North America Voglibose Sales by Type (2015-2020) (K MT)
Table 35. North America Voglibose Sales Market Share by Type (2015-2020)
Table 36. North America Voglibose Sales by Application (2015-2020) (K MT)
Table 37. North America Voglibose Sales Market Share by Application (2015-2020)
Table 38. Europe Voglibose Sales by Country (2015-2020) (K MT)
Table 39. Europe Voglibose Sales Market Share by Country (2015-2020)
Table 40. Europe Voglibose Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Voglibose Revenue Market Share by Country (2015-2020)
Table 42. Europe Voglibose Sales by Type (2015-2020) (K MT)
Table 43. Europe Voglibose Sales Market Share by Type (2015-2020)
Table 44. Europe Voglibose Sales by Application (2015-2020) (K MT)
Table 45. Europe Voglibose Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Voglibose Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Voglibose Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Voglibose Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Voglibose Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Voglibose Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Voglibose Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Voglibose Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Voglibose Sales Market Share by Application (2015-2020)
Table 54. Latin America Voglibose Sales by Country (2015-2020) (K MT)
Table 55. Latin America Voglibose Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Voglibose Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Voglibose Revenue Market Share by Country (2015-2020)
Table 58. Latin America Voglibose Sales by Type (2015-2020) (K MT)
Table 59. Latin America Voglibose Sales Market Share by Type (2015-2020)
Table 60. Latin America Voglibose Sales by Application (2015-2020) (K MT)
Table 61. Latin America Voglibose Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Voglibose Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Voglibose Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Voglibose Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Voglibose Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Voglibose Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Voglibose Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Voglibose Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Voglibose Sales Market Share by Application (2015-2020)
Table 70. Eris Corporation Information
Table 71. Eris Description and Major Businesses
Table 72. Eris Voglibose Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Eris Product
Table 74. Eris Recent Development
Table 75. Pfizer Limited Corporation Information
Table 76. Pfizer Limited Description and Major Businesses
Table 77. Pfizer Limited Voglibose Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Pfizer Limited Product
Table 79. Pfizer Limited Recent Development
Table 80. AS Pharma Corporation Information
Table 81. AS Pharma Description and Major Businesses
Table 82. AS Pharma Voglibose Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. AS Pharma Product
Table 84. AS Pharma Recent Development
Table 85. Sarian Corporation Information
Table 86. Sarian Description and Major Businesses
Table 87. Sarian Voglibose Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Sarian Product
Table 89. Sarian Recent Development
Table 90. Three Dots Lifesciences Corporation Information
Table 91. Three Dots Lifesciences Description and Major Businesses
Table 92. Three Dots Lifesciences Voglibose Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Three Dots Lifesciences Product
Table 94. Three Dots Lifesciences Recent Development
Table 95. Strides Corporation Information
Table 96. Strides Description and Major Businesses
Table 97. Strides Voglibose Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Strides Product
Table 99. Strides Recent Development
Table 100. Blue Cross Corporation Information
Table 101. Blue Cross Description and Major Businesses
Table 102. Blue Cross Voglibose Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Blue Cross Product
Table 104. Blue Cross Recent Development
Table 105. Life Care Corporation Information
Table 106. Life Care Description and Major Businesses
Table 107. Life Care Voglibose Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Life Care Product
Table 109. Life Care Recent Development
Table 110. Nexus Biotech Corporation Information
Table 111. Nexus Biotech Description and Major Businesses
Table 112. Nexus Biotech Voglibose Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Nexus Biotech Product
Table 114. Nexus Biotech Recent Development
Table 115. Neelkanth Healthcare (P)Ltd Corporation Information
Table 116. Neelkanth Healthcare (P)Ltd Description and Major Businesses
Table 117. Neelkanth Healthcare (P)Ltd Voglibose Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Neelkanth Healthcare (P)Ltd Product
Table 119. Neelkanth Healthcare (P)Ltd Recent Development
Table 120. Panacea Biotec Ltd Corporation Information
Table 121. Panacea Biotec Ltd Description and Major Businesses
Table 122. Panacea Biotec Ltd Voglibose Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Panacea Biotec Ltd Product
Table 124. Panacea Biotec Ltd Recent Development
Table 125. Unichem Corporation Information
Table 126. Unichem Description and Major Businesses
Table 127. Unichem Voglibose Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Unichem Product
Table 129. Unichem Recent Development
Table 130. Global Voglibose Sales Forecast by Regions (2021-2026) (K MT)
Table 131. Global Voglibose Sales Market Share Forecast by Regions (2021-2026)
Table 132. Global Voglibose Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 133. Global Voglibose Revenue Market Share Forecast by Regions (2021-2026)
Table 134. North America: Voglibose Sales Forecast by Country (2021-2026) (K MT)
Table 135. North America: Voglibose Revenue Forecast by Country (2021-2026) (US$ Million)
Table 136. Europe: Voglibose Sales Forecast by Country (2021-2026) (K MT)
Table 137. Europe: Voglibose Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Asia Pacific: Voglibose Sales Forecast by Region (2021-2026) (K MT)
Table 139. Asia Pacific: Voglibose Revenue Forecast by Region (2021-2026) (US$ Million)
Table 140. Latin America: Voglibose Sales Forecast by Country (2021-2026) (K MT)
Table 141. Latin America: Voglibose Revenue Forecast by Country (2021-2026) (US$ Million)
Table 142. Middle East and Africa: Voglibose Sales Forecast by Country (2021-2026) (K MT)
Table 143. Middle East and Africa: Voglibose Revenue Forecast by Country (2021-2026) (US$ Million)
Table 144. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 145. Key Challenges
Table 146. Market Risks
Table 147. Main Points Interviewed from Key Voglibose Players
Table 148. Voglibose Customers List
Table 149. Voglibose Distributors List
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Voglibose Product Picture
Figure 2. Global Voglibose Sales Market Share by Type in 2020 & 2026
Figure 3. Tabelts Product Picture
Figure 4. Capsules Product Picture
Figure 5. Others Product Picture
Figure 6. Global Voglibose Sales Market Share by Application in 2020 & 2026
Figure 7. Hospital
Figure 8. Clinics
Figure 9. Drug Store
Figure 10. Others
Figure 11. Voglibose Report Years Considered
Figure 12. Global Voglibose Market Size 2015-2026 (US$ Million)
Figure 13. Global Voglibose Sales 2015-2026 (K MT)
Figure 14. Global Voglibose Market Size Market Share by Region: 2020 Versus 2026
Figure 15. Global Voglibose Sales Market Share by Region (2015-2020)
Figure 16. Global Voglibose Sales Market Share by Region in 2019
Figure 17. Global Voglibose Revenue Market Share by Region (2015-2020)
Figure 18. Global Voglibose Revenue Market Share by Region in 2019
Figure 19. Global Voglibose Sales Share by Manufacturer in 2019
Figure 20. The Top 10 and 5 Players Market Share by Voglibose Revenue in 2019
Figure 21. Voglibose Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 22. Global Voglibose Sales Market Share by Type (2015-2020)
Figure 23. Global Voglibose Sales Market Share by Type in 2019
Figure 24. Global Voglibose Revenue Market Share by Type (2015-2020)
Figure 25. Global Voglibose Revenue Market Share by Type in 2019
Figure 26. Global Voglibose Market Share by Price Range (2015-2020)
Figure 27. Global Voglibose Sales Market Share by Application (2015-2020)
Figure 28. Global Voglibose Sales Market Share by Application in 2019
Figure 29. Global Voglibose Revenue Market Share by Application (2015-2020)
Figure 30. Global Voglibose Revenue Market Share by Application in 2019
Figure 31. North America Voglibose Sales Growth Rate 2015-2020 (K MT)
Figure 32. North America Voglibose Revenue Growth Rate 2015-2020 (US$ Million)
Figure 33. North America Voglibose Sales Market Share by Country in 2019
Figure 34. North America Voglibose Revenue Market Share by Country in 2019
Figure 35. U.S. Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 36. U.S. Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Canada Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 38. Canada Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. North America Voglibose Market Share by Type in 2019
Figure 40. North America Voglibose Market Share by Application in 2019
Figure 41. Europe Voglibose Sales Growth Rate 2015-2020 (K MT)
Figure 42. Europe Voglibose Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. Europe Voglibose Sales Market Share by Country in 2019
Figure 44. Europe Voglibose Revenue Market Share by Country in 2019
Figure 45. Germany Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 46. Germany Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. France Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 48. France Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. U.K. Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 50. U.K. Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Italy Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 52. Italy Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Russia Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 54. Russia Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Europe Voglibose Market Share by Type in 2019
Figure 56. Europe Voglibose Market Share by Application in 2019
Figure 57. Asia Pacific Voglibose Sales Growth Rate 2015-2020 (K MT)
Figure 58. Asia Pacific Voglibose Revenue Growth Rate 2015-2020 (US$ Million)
Figure 59. Asia Pacific Voglibose Sales Market Share by Region in 2019
Figure 60. Asia Pacific Voglibose Revenue Market Share by Region in 2019
Figure 61. China Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 62. China Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Japan Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 64. Japan Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. South Korea Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 66. South Korea Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. India Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 68. India Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Australia Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 70. Australia Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Taiwan Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 72. Taiwan Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Indonesia Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 74. Indonesia Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Thailand Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 76. Thailand Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Malaysia Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 78. Malaysia Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Philippines Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 80. Philippines Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Vietnam Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 82. Vietnam Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Asia Pacific Voglibose Market Share by Type in 2019
Figure 84. Asia Pacific Voglibose Market Share by Application in 2019
Figure 85. Latin America Voglibose Sales Growth Rate 2015-2020 (K MT)
Figure 86. Latin America Voglibose Revenue Growth Rate 2015-2020 (US$ Million)
Figure 87. Latin America Voglibose Sales Market Share by Country in 2019
Figure 88. Latin America Voglibose Revenue Market Share by Country in 2019
Figure 89. Mexico Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 90. Mexico Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 91. Brazil Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 92. Brazil Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Argentina Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 94. Argentina Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Latin America Voglibose Market Share by Type in 2019
Figure 96. Latin America Voglibose Market Share by Application in 2019
Figure 97. Middle East and Africa Voglibose Sales Growth Rate 2015-2020 (K MT)
Figure 98. Middle East and Africa Voglibose Revenue Growth Rate 2015-2020 (US$ Million)
Figure 99. Middle East and Africa Voglibose Sales Market Share by Country in 2019
Figure 100. Middle East and Africa Voglibose Revenue Market Share by Country in 2019
Figure 101. Turkey Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 102. Turkey Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 103. Saudi Arabia Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 104. Saudi Arabia Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. U.A.E Voglibose Sales Growth Rate (2015-2020) (K MT)
Figure 106. U.A.E Voglibose Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. Middle East and Africa Voglibose Market Share by Type in 2019
Figure 108. Middle East and Africa Voglibose Market Share by Application in 2019
Figure 109. North America Voglibose Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 110. North America Voglibose Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 111. Europe Voglibose Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. Europe Voglibose Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Asia Pacific Voglibose Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Asia Pacific Voglibose Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Latin America Voglibose Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Latin America Voglibose Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Middle East and Africa Voglibose Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Middle East and Africa Voglibose Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Porter's Five Forces Analysis
Figure 120. Channels of Distribution
Figure 121. Distributors Profiles
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed
リテールクリニック・インストアヘルスケアの世界市場（～2026年） Market Analysis and Insights: Global Retail Clinics In Store Healthcare Market The global Retail Clinics In Store Healthcare market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Retail Clinics In Store Healthcare Scope and …- ナップカプセルの世界市場（～2026年） Nap pod is the special chair or cubicle, used to allow people to take nap often at the workstation and or in corporate places. Nap pod is also known as energy pod or nap capsule. Nap pod allows employees to take a short 15-20 minute nap which is in the effective and easy way. Nap pod takes off the p…
- 有機カプセルの世界市場（～2026年） Organic capsule is a kind of capsule, compared to ordinary capsule, it is more natural alternative, starch-free, gluten-free, preservative-free, vegetable origin and non-GMO. Market Analysis and Insights: Global Organic Capsules Market The global Organic Capsules market size is projected to reach US…
- 特殊カプセルの世界市場（～2026年） Specialty Capsule refers to capsule that developed from special kind of raw material. In this report, it can be divided into coffee Capsules, gelatin Capsules Market Analysis and Insights: Global Specialty Capsules Market The global Specialty Capsules market size is projected to reach US$ XX million…
- 液体充填カプセルの世界市場（～2026年） Liquid-filled capsule is the gelatin shell which is for liquid, semi-solid, paste and multiparticulate applications. It has good bioavailability, and can be safely dissolved quickly and reliably. Market Analysis and Insights: Global Liquid-filled Capsules Market The global Liquid-filled Capsules mar…